Phase III trial results of novel triple combination pill for hypertension published in The Lancet
October 18, 2024 07:00 ET
|
George Medicines
Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill significantly reduced blood pressure and improved control rates vs dual...
Ivy Brain Tumor Center to Present Multiple Abstracts and a Special Session on Innovative Clinical Trial Design at the 2024 European Association of Neuro-Oncology Annual Meeting
October 17, 2024 06:00 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute will present updated study results and a special session on clinical trial design at the...
Clinical Trials Market Size to Worth USD 85.37 Billion by 2033 | Straits Research
October 15, 2024 10:55 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Clinical trials are critical in proceeding with medical knowledge and improving patient care. They involve a rigorous process of recruiting...
Adaptive Research Launches Decentralized Clinical Trial in Parkinson’s Disease
October 15, 2024 08:30 ET
|
Adaptive Research Inc
Adaptive Research announced its participation in a decentralized study for Parkinsons’ Disease sponsored by PhotoPharmics Inc.
Adaptive Research Announces it has Begun Enrolling Patients in AriBio’s Phase 3 POLARIS-AD Clinical Trial
September 30, 2024 08:00 ET
|
Adaptive Research Inc
Adaptive Research announced it has begun enrolling patients in
AriBio’s Phase 3 POLARIS-AD Clinical Trial.
Pharmaceuticals and Biotechnology Option and Evaluation Deal Trends Report 2024 with Directory of Deals Signed Since 2016
September 23, 2024 06:41 ET
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Option and...
Ivy Brain Tumor Center’s Dr. Nader Sanai Named Arizona Bioscience Researcher of the Year
September 17, 2024 11:00 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Dr. Nader Sanai, Director of the Ivy Brain Tumor Center, Chief of Neurosurgical Oncology at Barrow Neurological Institute, and the Francis &...
BAMF Health Announces Strategic Clinical Trials Partnership with Adaptive Research
September 16, 2024 08:30 ET
|
Adaptive Research Inc
BAMF Health and Adaptive Research announced a strategic partnership to increase physician participation and patient enrollment in clinical trials.
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
September 16, 2024 08:00 ET
|
Science 37, Inc.
MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Today, Science 37, a leader in enhancing patient access to clinical trials, announced that it has received Frost & Sullivan’s 2024 Global...
CD47 Inhibitor Drug Clinical Trials Market Outlook to 2028 - Emerging CD47 Inhibitor Clinical Trials Showcase Potential Cancer Treatment Breakthroughs
September 06, 2024 06:48 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering....